* Diebold Nixdorf Inc DBD.N DBD is expected to show a
fall in
quarterly revenue when it reports results on October 26
(estimated).
* The North Canton Ohio-based company is expected to report
a
12.0% decrease in revenue to $843.463 million from $958.2
million a year ago, according to the mean estimate from 3
analysts, based on Refinitiv data.
* Refinitiv's mean analyst estimate for Diebold Nixdorf Inc
is
for earnings of 25 cents per share.
* The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 3
"hold" and 1 "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Diebold
Nixdorf
Inc is $4, above its last closing price of $2.21.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Jun. 30 2022 -0.12 -0.14 0.38 Beat 371.4
Mar. 31 2022 -0.22 -0.21 -1.61 Missed -648.8
Dec. 31 2021 0.56 0.57 0.06 Missed -89.4
Sep. 30 2021 0.51 0.51 0.34 Missed -33.3
Jun. 0.28 0.28 0.10 Missed -64.6
30 2021
Mar. 31 2021 0.18 0.20 0.29 Beat 42.6
Dec. 31 2020 0.36 0.36 0.44 Beat 23.4
Sep. 30 2020 0.23 0.23 0.28 Beat 21.7
This summary was machine generated October 24 at 14:32 GMT. All
figures in US dollars unless otherwise stated